Summary of "Preventive Medicines | Cholera | Malaria | Dengue | Influenza | Unit 2 Social & Preventive Pharmacy"

High-level overview (purpose and approach)

• Topic: Unit 2 of Social & Preventive Pharmacy — “Preventive Medicine.”
• Goal: Focus on preventing disease and promoting health rather than treating illness after it occurs.
• Teaching pattern used for each disease:
  • Brief introduction
  • Causative agent
  • Mode(s) of transmission
  • Key signs & symptoms
  • General principles of prevention & control
• Scope: Diseases in the syllabus were divided into communicable (10) and non‑communicable (4); the lecture covered all of them.

Classification

• Communicable diseases covered (10):
  • Cholera; SARS (coronavirus/COVID-type respiratory disease); Ebola virus disease; influenza; acute respiratory infections (ARIs); malaria; chikungunya; dengue; lymphatic filariasis; pneumonia.
• Non‑communicable / lifestyle diseases covered (4):
  • Hypertension; diabetes mellitus; cancer; drug addiction / substance abuse.

Common prevention principles emphasized

• Personal hygiene: frequent handwashing, food hygiene, avoid touching face.
• Respiratory hygiene: masks, covering mouth/nose, avoiding close contact.
• Early recognition and timely medical care; isolation/quarantine when infectious.
• Environmental sanitation and community participation: safe water, sewage disposal, remove stagnant water.
• Vaccination where applicable (disease‑specific; e.g., influenza — annual vaccine; cholera vaccines in high‑risk settings).
• Health education and awareness to change behaviours and improve uptake of preventive measures.
• Nutrition and maintaining immune health.
• Vector control (for mosquito‑borne diseases): eliminate breeding sites, use insecticides/larvicides, bed nets, window screens, repellents, protective clothing.
• Safe handling / infection control in healthcare: PPE, safe disposal of contaminated materials, disinfect surfaces, safe handling of bodies for hemorrhagic diseases.

Detailed summaries (disease by disease)

1) Cholera

• Causative agent: Vibrio cholerae (Gram‑negative bacterium).
• Transmission: Fecal–oral route — contaminated water or food, poor sanitation, flies, inadequate handwashing.
• Key symptoms: Profuse watery diarrhea, vomiting → severe dehydration, electrolyte imbalance, hypotension, weakness, potential hypovolemic shock and death if untreated.
• Prevention & control:
  • Provide safe drinking water (boil or filter); protect and cover stored water.
  • Maintain sanitation and human waste disposal; prevent open defecation.
  • Personal and food hygiene; wash fruits/vegetables; avoid street/unsafe food.
  • Oral rehydration salts (ORS) and timely medical care to correct dehydration/electrolytes.
  • Vaccination in high‑risk areas (oral cholera vaccines used in outbreaks).
  • Community education and participation.

2) SARS / Coronavirus‑type acute respiratory syndrome

• Causative agent: SARS coronavirus (coronavirus family).
• Transmission: Primarily respiratory droplets; contaminated surfaces (fomites); close contact.
• Key symptoms: Fever, dry cough, difficulty breathing, headache, muscle pain, fatigue; can progress to pneumonia and respiratory failure.
• Prevention & control:
  • Hand hygiene, mask use, respiratory etiquette, maintain physical distance.
  • Surface disinfection; avoid touching face.
  • Early symptom recognition, testing, isolation/quarantine of cases.
  • Supportive medical care and symptom management; protect vulnerable people.
  • Health education and vaccination programs when applicable.

3) Ebola virus disease

• Causative agent: Ebola virus (a filovirus).
• Transmission: Direct contact with infected body fluids (blood, vomit, saliva, sweat, urine), contaminated objects, contact with infected animals (bats, primates).
• Key symptoms: High fever, severe weakness, headache, muscle pain, vomiting, diarrhea, abdominal pain, uncontrolled bleeding (internal/external), shock, organ failure, high fatality.
• Prevention & control:
  • Strict personal hygiene; avoid direct contact with body fluids.
  • Use PPE, gloves, masks and protective clothing for caregivers and health workers.
  • Safe handling and burial practices for corpses.
  • Disinfection of contaminated surfaces and objects.
  • Early diagnosis, isolation and supportive care; community awareness.

4) Influenza (flu)

• Causative agent: Influenza viruses (A, B, C); Influenza A subtypes characterized by HA (H) and NA (N) proteins.
• Transmission: Respiratory droplets and close contact.
• Key symptoms: Fever, cough, sore throat, nasal congestion/runny nose, body aches, fatigue; can progress to pneumonia in severe cases or high‑risk groups.
• Prevention & control:
  • Hand and respiratory hygiene, masks, avoid close contact.
  • Annual influenza vaccination (inactivated or live‑attenuated vaccines); vaccine composition updated yearly.
  • Early diagnosis and symptomatic treatment; supportive care, rest, hydration.
  • Health education about hygiene, vaccination and risk reduction.

5) Acute respiratory infections (ARIs)

• Causative agents: Multiple viruses (influenza, coronavirus, RSV, adenovirus, rhinovirus) and bacteria (Streptococcus pneumoniae, Haemophilus influenzae).
• Transmission: Respiratory droplets and close contact.
• Key symptoms: Cough, fever, sore throat, nasal symptoms, difficulty breathing; severity varies.
• Prevention & control:
  • Standard respiratory and personal hygiene, covering coughs/sneezes, masks.
  • Vaccination where available (influenza, pneumococcal vaccines).
  • Early recognition and treatment; maintain clean environments; nutrition to support immunity.

6) Malaria

• Causative agent: Plasmodium species (P. vivax, P. falciparum, P. malariae, P. ovale).
• Transmission: Bite of infected female Anopheles mosquito (human ↔ mosquito cycle); rare transmission via blood transfusion, contaminated needles, mother‑to‑child.
• Key symptoms: Fever with chills, sweating, headache, body aches, vomiting; severe disease → anemia, coma, death.
• Prevention & control:
  • Mosquito control: eliminate stagnant water, environmental sanitation, larval control.
  • Personal protection: insecticide‑treated bed nets, window screens, repellents, full‑coverage clothing.
  • Insecticide sprays and community vector control.
  • Early diagnosis (blood tests) and prompt antimalarial treatment.
  • Health education about avoiding mosquito bites.

7) Chikungunya

• Causative agent: Chikungunya virus.
• Transmission: Aedes mosquitoes (Aedes aegypti, Aedes albopictus), daytime biters.
• Key symptoms: Sudden high fever and severe joint pain (often debilitating and long‑lasting), headache, muscle pain, rash, weakness.
• Prevention & control:
  • Mosquito control and personal protection measures similar to malaria/dengue (remove breeding sites, nets, repellents, protective clothing).
  • Early diagnosis, supportive care, rest and symptomatic treatment.
  • Community awareness of mosquito avoidance.

8) Dengue

• Causative agent: Dengue virus (four serotypes: DENV‑1 to DENV‑4).
• Transmission: Aedes aegypti mosquitoes (daytime) via mosquito bite cycle.
• Key symptoms: Sudden high fever, severe headache (often retro‑orbital), severe muscle and joint pain, rash, nausea/vomiting; severe cases → hemorrhagic manifestations, thrombocytopenia, dengue hemorrhagic fever/shock.
• Prevention & control:
  • Eliminate mosquito breeding (stagnant water), personal protection (repellents, nets, full clothing), environmental control.
  • Early recognition and supportive medical care; platelet monitoring.
  • Community education and vector control programs.

9) Lymphatic filariasis (filariasis)

• Causative agent: Filarial worms (Wuchereria bancrofti, Brugia malayi, etc.).
• Transmission: Mosquito vectors (commonly Culex species in many areas) transmit filarial larvae which settle in lymphatic system.
• Key symptoms: Fever, localized swelling (lymphedema), hydrocele in males, thickening of skin and tissues (elephantiasis) leading to chronic disability and disfigurement.
• Prevention & control:
  • Mosquito control and personal protection (remove breeding sites, nets, repellents).
  • Early diagnosis and antiparasitic treatment; morbidity management for lymphedema.
  • Community mass drug administration programs where endemic.
  • Health education and hygienic care of affected limbs.

10) Pneumonia

• Causative agents: Bacteria (e.g., Streptococcus pneumoniae), viruses (influenza, RSV, SARS, etc.), occasionally fungi.
• Pathology: Alveoli filled with fluid/pus → impaired gas exchange → difficulty breathing.
• Key symptoms: Fever, cough, chest pain, difficulty breathing, fatigue; severe cases → hypoxia, cyanosis, confusion.
• Prevention & control:
  • Respiratory hygiene, handwashing, avoid smoking (lung health).
  • Vaccination where indicated (pneumococcal vaccines PCV‑types, influenza vaccines).
  • Good nutrition, early diagnosis and prompt antibiotic/antiviral therapy when indicated.
  • Maintain clean environment and access to medical care.

Non‑communicable / lifestyle disorders

11) Hypertension

• Definition: Chronically elevated blood pressure; stages described (normal, prehypertension, stage 1, stage 2) with systolic/diastolic thresholds.
• Major risk factors: High salt intake, obesity, stress, sedentary lifestyle, smoking, alcohol, family history, vascular changes.
• Symptoms: Often asymptomatic (“silent”), but may present with headache, dizziness, shortness of breath, nosebleeds, chest pain.
• Prevention & control:
  • Diet low in salt; increased fruit & vegetable intake.
  • Regular exercise and weight management.
  • Avoid smoking and limit/stop alcohol.
  • Stress management, adequate sleep.
  • Regular blood pressure monitoring and medication adherence when prescribed.
  • Health education on lifestyle modification.

12) Diabetes mellitus

• Pathophysiology: Elevated blood glucose due to insulin deficiency (Type 1) or insulin resistance (Type 2); gestational diabetes also possible.
  • Type 1: Autoimmune beta‑cell destruction → insulin deficiency → requires insulin treatment.
  • Type 2: Insulin present but cells resistant; most common (~90%); linked to obesity, sedentary lifestyle, diet.
• Key symptoms: Polyuria, polydipsia, polyphagia, weight loss, fatigue, slow wound healing, vision problems.
• Prevention & control:
  • Healthy diet (reduced simple carbohydrates), emphasis on fiber and protein; weight control.
  • Regular physical activity; glycemic monitoring.
  • Medications/insulin therapy when needed; early detection in prediabetes can prevent progression.
  • Stress management, proper sleep, education.

13) Cancer

• Definition: Uncontrolled growth of abnormal cells forming tumors; can metastasize (spread) to other body parts.
• Types noted: Carcinoma (epithelial origin), sarcoma (connective tissue), lymphoma (lymphatic system), leukemia (blood).
• Risk factors: Tobacco, alcohol, unhealthy diet, radiation, certain infections, family history, exposure to carcinogens.
• Early signs: Often nonspecific — fatigue, weight change, persistent cough, unexplained bleeding, lumps, skin changes, night sweats.
• Prevention & control:
  • Avoid tobacco, limit alcohol, healthy diet and regular exercise.
  • Vaccination where relevant (e.g., hepatitis B, HPV) to prevent virus‑associated cancers.
  • Protect from unnecessary radiation; limit exposure to carcinogens.
  • Screening & early detection (breast screening, etc.).
  • Treatment options: surgery, chemotherapy, radiotherapy, hormone therapy, immunotherapy.

14) Drug addiction and substance abuse

• Definitions: Addiction = compulsive drug use despite harm; abuse = improper use of drugs (medicinal or illicit) for non‑therapeutic reasons.
• Causes/risk factors: Peer pressure, stress, depression, curiosity, easy availability, family history/genetics.
• Signs & symptoms: Strong craving, behavior changes, mood swings, loss of control, neglect of responsibilities, health deterioration.
• Prevention & control:
  • Health education, community awareness, refusal skills.
  • Family support, counseling and psychological interventions.
  • Early detection and referral to treatment/rehabilitation programs.
  • Regulation and control of drug supply; policies to reduce availability.
  • Medical treatments and support for detoxification and relapse prevention.

Speaker / source

Lecture / narration: Ashit Pandey (presenting under “Perfect Pharmacy” / the course’s YouTube content).

Category

Educational

---

Share this summary

Share on X/Twitter Share on Facebook Share on LinkedIn Share on Reddit Share on WhatsApp Share on Telegram

---

Is the summary off?

If you think the summary is inaccurate, you can reprocess it with the latest model.

Reprocess summary

Video